News Chart Perspective Therapeutics, Inc.

Stocks

CATX

US46489V3024

Biotechnology & Medical Research

Market Closed - NYSE 16:00:00 2026-10-19 EDT			5-day change	1st Jan Change
2.190 ^USD	+0.92%		-13.10%	-20.36%

10-08	Perspective Therapeutics, Inc. Receives Fast Track Designation for PSV359 for Treatment of Adult Patients with Locally Advanced Unresectable And/Or Metastatic FAP-Positive Solitary Fibrous Tumors	CI
10-08	Perspective's Cancer Therapy Candidate Receives FDA Fast Track Designation; Shares Rise Pre-Bell	MT

32075ede0235296fdf9e6ef35.-OCaXoxqlOAFFhxAZYIwI_jWcYbxtNN-5zDc47IjvIE.ta7LJ-AawpJMe1kiBvdSQp-YCOuz8YYajHOp1cVW8vCXsa1v_Qb1hkBAbw~0173067d71c8fa0fdaf56adefd67c254